Medifast
MED
#9085
Rank
A$0.18 B
Marketcap
A$16.38
Share price
0.18%
Change (1 day)
-47.07%
Change (1 year)

Revenue for Medifast (MED)

Revenue in 2025 (TTM): A$0.67 Billion

According to Medifast's latest financial reports the company's current revenue (TTM ) is A$0.64 Billion. In 2024 the company made a revenue of A$0.96 Billion a decrease over the revenue in the year 2023 that were of A$1.57 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Medifast from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$0.67 B-30.58%
2024 A$0.96 B-38.45%
2023 A$1.57 B-33.02%
2022 A$2.34 B11.6%
2021 A$2.10 B73.14%
2020 A$1.21 B19.27%
2019 A$1.01 B43.33%
2018 A$0.71 B84.11%
2017 A$0.38 B1.42%
2016 A$0.38 B1.72%
2015 A$0.37 B14.83%
2014 A$0.32 B-18.5%
2013 A$0.40 B16.56%
2012 A$0.34 B18.03%
2011 A$0.29 B14.7%
2010 A$0.25 B35.07%
2009 A$0.18 B25.6%
2008 A$0.14 B55.97%
2007 A$95.82 M1.96%
2006 A$93.98 M71.36%
2005 A$54.84 M55.24%
2004 A$35.32 M3.47%
2003 A$34.14 M55.82%
2002 A$21.91 M122.67%
2001 A$9.84 M41.15%
2000 A$6.97 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
A$0.96 B 49.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bellerophon Therapeutics
BLPH
A$8.49 M-98.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
A$0.6 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA